Kevin M Biglan

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi Telemedicine for the care of nursing home residents with Parkinson's disease
    Kevin M Biglan
    Department of Neurology, University of Rochester Medical Center, Rochester, NY 14620, USA
    Mov Disord 24:1073-6. 2009
  2. ncbi Surrogate endpoints in Parkinson's disease research
    Kevin M Biglan
    Department of Neurology, University of Rochester, 1351 Mt Hope Avenue, Rochester, NY 14620, USA
    Curr Neurol Neurosci Rep 3:314-20. 2003
  3. ncbi Risk factors for somnolence, edema, and hallucinations in early Parkinson disease
    Kevin M Biglan
    University of Rochester, Department of Neurology, Rochester, NY 14620, USA
    Neurology 69:187-95. 2007
  4. ncbi Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, New York 14620, USA
    Mov Disord 25:1652-9. 2010
  5. ncbi Rasagiline improves quality of life in patients with early Parkinson's disease
    Kevin M Biglan
    Department of Neurology, Johns Hopkins University, Baltimore, Maryland 21287, USA
    Mov Disord 21:616-23. 2006
  6. ncbi A U.S. survey of patients with Parkinson's disease: satisfaction with medical care and support groups
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, New York 14620, USA
    Mov Disord 25:2128-35. 2010
  7. ncbi Neuroprotection in Parkinson's disease: an elusive goal
    Kevin M Biglan
    Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14620, USA
    Semin Neurol 27:106-12. 2007
  8. ncbi Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study
    Kevin M Biglan
    University of Rochester, Rochester, New York, USA
    Mov Disord 24:1763-72. 2009
  9. ncbi A review of pramipexole and its clinical utility in Parkinson's disease
    Kevin M Biglan
    University of Rochester, Department of Neurology, 1351 Mt Hope Avenue, Suite 220, Rochester, NY 14620, USA
    Expert Opin Pharmacother 3:197-210. 2002

Detail Information

Publications10

  1. ncbi Telemedicine for the care of nursing home residents with Parkinson's disease
    Kevin M Biglan
    Department of Neurology, University of Rochester Medical Center, Rochester, NY 14620, USA
    Mov Disord 24:1073-6. 2009
    ..The visits resulted in improvements in motor and cognitive symptoms and suggest that telemedicine may be useful for delivering care to this population...
  2. ncbi Surrogate endpoints in Parkinson's disease research
    Kevin M Biglan
    Department of Neurology, University of Rochester, 1351 Mt Hope Avenue, Rochester, NY 14620, USA
    Curr Neurol Neurosci Rep 3:314-20. 2003
    ..Finally, the significant challenges that lie ahead for validating and interpreting surrogate endpoints in PD are addressed...
  3. ncbi Risk factors for somnolence, edema, and hallucinations in early Parkinson disease
    Kevin M Biglan
    University of Rochester, Department of Neurology, Rochester, NY 14620, USA
    Neurology 69:187-95. 2007
    ..A secondary finding of the trial was a higher than anticipated development or worsening of somnolence and edema and development of hallucinations...
  4. ncbi Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, New York 14620, USA
    Mov Disord 25:1652-9. 2010
    ..Providing subspecialty care via telemedicine for individuals with Parkinson's disease living remotely is feasible...
  5. ncbi Rasagiline improves quality of life in patients with early Parkinson's disease
    Kevin M Biglan
    Department of Neurology, Johns Hopkins University, Baltimore, Maryland 21287, USA
    Mov Disord 21:616-23. 2006
    ..Rasagiline improved QOL compared with placebo. This QOL improvement appears to be accounted for primarily by the symptomatic benefit of rasagiline...
  6. ncbi A U.S. survey of patients with Parkinson's disease: satisfaction with medical care and support groups
    E Ray Dorsey
    Department of Neurology, University of Rochester Medical Center, Rochester, New York 14620, USA
    Mov Disord 25:2128-35. 2010
    ..Specialty care and improved education, in the clinic or through support groups, may enhance satisfaction and health care quality...
  7. ncbi Neuroprotection in Parkinson's disease: an elusive goal
    Kevin M Biglan
    Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14620, USA
    Semin Neurol 27:106-12. 2007
    ..Ultimately, overcoming the unique challenges of a heterogenous, slowly progressive disorder with multiple potential outcome measures will be necessary to identify treatments that have meaningful effects...
  8. ncbi Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study
    Kevin M Biglan
    University of Rochester, Rochester, New York, USA
    Mov Disord 24:1763-72. 2009
    ..Longitudinal assessment will help inform whether motor items will be useful measures in preventive clinical trials...
  9. ncbi A review of pramipexole and its clinical utility in Parkinson's disease
    Kevin M Biglan
    University of Rochester, Department of Neurology, 1351 Mt Hope Avenue, Suite 220, Rochester, NY 14620, USA
    Expert Opin Pharmacother 3:197-210. 2002
    ..In addition to its use in PD, pramipexole has shown some utility in the treatment of restless legs syndrome (RLS), depression and schizophrenia...